ProKidney Corp Ordinary Live Stock Price Today, Share Analysis and Chart

Name: ProKidney Corp - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: ProKidney Corp - Ordinary Shares - Class A
Rating: 0.73241675
Author: Trendlyne DVM scores

about

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its prod...

1.66 -0.05 (-2.92%)

76.72% Fall from 52W High

884.0K

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for ProKidney Corp Ordinary is on 19 May 2026 for the purpose of ProKidney Corp First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

1.2 / 100

Technically Bearish

28.1 / 100

1Yr Price target upside is 277%

6 analysts

ProKidney Corp Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ProKidney Corp Ordinary Live Stock Price Today, Share Analysis and Chart

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its prod...

76.72% Fall from 52W High

SWOT Analysis

ProKidney Corp Ordinary Live Price Chart